Safe handling of cytotoxics: guideline recommendations.
暂无分享,去创建一个
A C Easty | A. Easty | P. Savage | R. Cheng | P Savage | M Cividino | N Coakley | R Cheng | R Tozer | R E White | R. Tozer | M. Cividino | N. Coakley | R. White
[1] M. Slawson,et al. Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device , 2007 .
[2] M. Carey,et al. Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A Gafni,et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Pérol,et al. The PhaSeal® system: Impact of its use on workplace contamination and duration of chemotherapy preparation , 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[5] S. Kirsa,et al. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device , 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[6] J. Jaakkola,et al. Occupational exposures and adverse pregnancy outcomes among nurses: a systematic review and meta-analysis. , 2010, Journal of women's health.
[7] Carissa M Rocheleau,et al. Occupational exposures among nurses and risk of spontaneous abortion. , 2012, American journal of obstetrics and gynecology.
[8] I. Roos,et al. Human resource issues in cytotoxic drug dispensing , 1997 .
[9] P. Sessink,et al. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device , 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[10] Elisabeth Burdick,et al. Impact of robotic antineoplastic preparation on safety, workflow, and costs. , 2012, Journal of oncology practice.
[11] S. Kumagai,et al. Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan , 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.